Ophthalmology Template Tool

Free Intravitreal Injection Consent Form Template

Operational & Compliance DisclaimerDisclaimer: This template is a sample for operational and administrative purposes only. ConsentCollect is a software platform, not a law firm or a healthcare provider. Consult with qualified legal counsel and medical directors to ensure compliance with local regulations before deploying any clinical consent form.
Professional medical consent form template for Intravitreal Injection
ConsentCollect Logo

Informed Consent for Intravitreal Injection

Patient Informed Consent Documentation

Patient and Procedure Information

Nature and Purpose of the Procedure

An intravitreal injection is the administration of medication directly into the vitreous cavity (the jelly-filled space in the back of the eye) to treat diseases of the retina and macula. This treatment is commonly indicated for conditions such as wet age-related macular degeneration (AMD), diabetic macular edema, retinal vein occlusion, and choroidal neovascularization. The procedure is performed in an outpatient clinic setting under topical or local anesthesia. The eye is cleaned with an antiseptic solution (typically povidone-iodine) to reduce the risk of infection, and a small speculum is placed to keep the eyelids open. The physician uses a fine needle to inject the designated medication through the sclera (the white part of the eye). The injection itself takes only a few seconds. The physician will check the eye immediately post-injection to confirm light perception and normal retinal artery perfusion.

Need for Repeat Injections

Intravitreal therapy is generally not a one-time treatment. Pharmacological agents, particularly anti-VEGF (vascular endothelial growth factor) inhibitors, degrade over time and must be re-administered to maintain their therapeutic effect. Depending on your specific diagnosis and clinical response, you may require injections on a regular schedule (typically every 4 to 12 weeks) for an extended period, which could span several years. Your ophthalmologist will monitor your progress using optical coherence tomography (OCT) and clinical examinations to determine the ongoing frequency of injections.

Material Risks and Potential Complications

Endophthalmitis: a severe intraocular bacterial or fungal infection occurring in approximately 1 in 2,000 injections. Symptoms include worsening pain, progressive redness, and loss of vision, typically developing 2 to 5 days after the injection. Endophthalmitis is a medical emergency that requires urgent injection of intraocular antibiotics or surgery.
Intraocular pressure elevation: a transient increase in pressure immediately following the injection, caused by the volume of liquid introduced into the eye. This is common and usually resolves within an hour, but persistent elevation may require pressure-lowering drops or, rarely, a minor surgical decompression (paracentesis).
Systemic cardiovascular events (anti-VEGF class risk): there is a theoretical risk of arterial thromboembolic events (such as stroke or myocardial infarction) associated with systemic absorption of vascular endothelial growth factor inhibitors. This risk is extremely low but is carefully monitored in patients with a history of recent stroke or heart attack.
Vitreous hemorrhage: bleeding inside the eye from localized damage to blood vessels during needle insertion. This usually resolves spontaneously over several weeks but may cause floating spots or blurred vision.
Retinal tear or detachment: traction or damage to the retina caused by the needle or changes in the vitreous gel. This is rare (less than 1 percent) but requires surgical repair to prevent permanent vision loss.

Expected Benefits

The primary expected benefit of intravitreal injection is stabilization or improvement of visual acuity. Without treatment, diseases like wet AMD or diabetic macular edema typically lead to progressive, irreversible loss of central vision. While injections do not cure the underlying disease, they are highly effective in halting or slowing down abnormal blood vessel growth and leakage, thereby preserving functional vision.

Reasonable Alternatives to Injection

Laser photocoagulation: thermal laser treatment to seal leaking blood vessels. Laser treatment carries a risk of permanent localized blind spots and is less effective than injections for many macular conditions.
Photodynamic therapy (PDT): a combination of an intravenous drug and a non-thermal laser, occasionally used for specific macular diseases.
Observation: choosing no treatment, which carries a high risk of progressive, severe, and permanent central vision loss from bleeding, swelling, or scarring of the macula.

Right to Refuse or Withdraw Consent

You have the right to refuse this procedure or withdraw your consent at any time before the injection is administered without penalty or adverse effect on your medical care. Your ophthalmologist will discuss the visual prognosis associated with declining treatment.

Questions and Understanding Confirmation

I confirm that I have reviewed this consent form with my ophthalmologist. I understand the chronic nature of my condition, the necessity of repeated injections, the small risk of serious infection (endophthalmitis), and the theoretical systemic stroke risk. All my questions have been answered.

Language Access and Interpreter Services

If English is not your primary language or if you require assistance communicating, a qualified medical interpreter is available to you at no cost. Please notify your care team if you require interpreter services before signing this document.

Copy of Consent Acknowledgment

I acknowledge that I have been offered a signed copy of this informed consent form for my own records. I understand I may request an additional copy at any time from the facility or clinical records department.

Patient Authorization

I have been informed of the intravitreal injection procedure, its expected benefits, the material risks listed above, the chronic nature of the therapy, and available alternatives. I consent to receive the planned intravitreal injection in the target eye(s) indicated above.

Signatures and Verification

Document ID: CC-INTRAVITREAL-INJECTION-CONSENT-FORM
POWERED BY CONSENTCOLLECT

Need to print or customize this template?

Download a clean PDF copy or customize it in our Free Consent Builder. No account required.

Looking for a complete clinical workflow?

Standard PDF consent forms still leave your practice exposed to malpractice disputes. If you want verified patient comprehension quizzes, automated signing order tracking, biometric signature seals, and direct Epic/Cerner EHR FHIR R4 integration, then upgrade to our full ConsentCollect App.

Free Document Schema Specifications

Template Classification:Intravitreal Injection Layout
Target File Format:Printable PDF / HTML Structure
Customization Capability:Fully Editable Text & Checklist Fields
Licensing & Rights:Free Personal & Practice-Wide Use

How to Use the Digital Intravitreal Injection Consent Template

The Intravitreal Injection document layout available on this page is a structured administrative schema designed for ophthalmology practice managers, compliance coordinators, and healthcare operations teams. Ophthalmology consent form covering intravitreal injection of pharmacological agents, including anti-VEGF or corticosteroids, risk of endophthalmitis, and need for repeat injections.

Using the ConsentCollect Free Builder, administrative staff can import this intravitreal injection schema and configure every field to match their specific facility requirements. The builder supports drag-and-drop field reordering, custom label editing, signature block layout control, and client-side PDF generation, with no coding knowledge required and no account needed.

Once the intravitreal injection layout is finalized, it can be printed as a high-resolution paper document, embedded into a digital patient intake kiosk, or exported as a structured JSON payload for integration into an existing EHR or practice management system. Organizations running the full ConsentCollect App subscription gain access to verified comprehension tracking, automated signing sequence management, biometric signature seals, and FHIR R4 interoperability with Epic and Cerner platforms.

❓ Frequently Asked Questions

How do I import and configure this Intravitreal Injection document layout in the Free Builder?

Click the "Customize in Free Builder" button on this page. The form schema opens directly in the client-side ConsentCollect Free Builder canvas with all fields, sections, and signature blocks pre-loaded. You can then drag and drop additional fields, relabel any section header, swap placeholder text for your facility name and provider credentials, and rearrange the field order to match your clinic workflow, all without creating an account.

What document structure and field types does this Intravitreal Injection layout include?

This layout contains 12 structured sections covering patient identification fields, administrative intake data, and signature capture blocks. Practice managers and compliance officers can override any field label or placeholder value inside the builder to match their own intake schema.

Can I use this Intravitreal Injection template for my Ophthalmology practice without a paid subscription?

Yes. The Free Advanced Form Builder is entirely public with no account required. You can open this intravitreal injection layout, edit all fields, and export a print-ready PDF or copy the underlying JSON schema at no cost. A paid ConsentCollect App subscription unlocks additional workflow features such as encrypted transmission, timestamped audit logs, multi-party signing order, and direct FHIR R4 EHR integrations.

Does this page provide clinical, legal, or medical advice about intravitreal injection procedures?

No. This page is an administrative document schema tool hosted by ConsentCollect, a B2B compliance software platform. The form layout is provided for operational and administrative configuration purposes only. ConsentCollect is not a law firm, healthcare provider, or clinical advisory service. Before deploying any consent document to patients, the finished form must be reviewed by your organization's qualified legal counsel and a licensed medical director to confirm compliance with applicable regulations in your jurisdiction.

How do I export, print, or integrate this Intravitreal Injection form schema into my EHR system?

After editing in the Free Builder, use the Export button to download a high-resolution PDF suitable for physical signature collection. Alternatively, copy the JSON schema payload for use in your own patient intake database or web application. Subscribers to the full ConsentCollect App can push finalized templates directly into Epic or Cerner workflows via a certified FHIR R4 integration layer without any manual re-entry.